Melinda S Yates

8PUBLICATIONS
50CO-AUTHORS
Molecular targetsCancer geneticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 01, 2026
Oncogene SETDB1's dual role: driving tumor progression and immune escape.

|Jun 22, 2026
Allostatic Load in Endometrial Cancer Disparities.

|Jun 26, 2024
Long-Term Follow-up of Levonorgestrel Intrauterine Device for Atypical Hyperplasia and Early Endometrial Cancer Reveals Relapse Characterized by Immune Exhaustion.

Mikayla B Bowen, Brenda Melendez, Qian Zhang

|Jul 10, 2023
TIME for Bugs: The Immune Microenvironment and Microbes in Precancer.

Mikayla Borthwick Bowen, Beth A Helmink, Jennifer A Wargo

|Jan 10, 2023
Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Christopher P Vellano, Michael G White, Miles C Andrews

|Jun 15, 2022
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy.

Christopher P Vellano, Michael G White, Miles C Andrews

Pageof 2

Frequent Collaborators

4 joint publications

Mikayla S Borthwick

4 joint publications

Shannon N Westin

4 joint publications

Jennifer A Wargo

3 joint publications

Alexander J Lazar